[Effectiveness and safety of robotic surgery: rectal and colon cancers, benign and malignant pancreatic tumours, and obesity]
Collette C
Record ID 32018015697
French
Original Title:
Efficacité et innocuité de la chirurgie robotique : cancers du rectum et du côlon, tumeurs bénignes ou malignes du pancréas et obésité
Authors' objectives:
The Ministère de la Santé et des Services sociaux’s Surgical Services Division (which
has been transferred to Santé Québec) mandated the Institut national d’excellence en
santé et en services sociaux to analyse the evidence regarding the effectiveness and
safety of using robots in surgery for rectal and colon cancers, benign and malignant
pancreatic tumours, and obesity. Prioritization was based on the requester’s needs, the
availability of literature, and the growing use of robotic systems in Québec since 2018 for
these indications.
Authors' results and conclusions:
RESULTS (#1 ROBOTIC SURGERY: AN APPROACH AT LEAST COMPARABLE TO LAPAROSCOPIC SURGERY,
TRANSANAL SURGERY AND OPEN SURGERY): The findings of this project are consistent with those of other health
technology assessment agencies and are in line with the recommendations of learned
societies and professional medical associations in colorectal and pancreatic surgery. (#2 KEY POINTS ABOUT ROBOTIC SURGERY FOR RECTAL CANCER): Robotic surgery appears to be comparable to the laparoscopic, transanal and/or open
approaches in terms of:
• The probability of postoperative complications of any severity and of
anastomotic leaks, and the estimated blood loss (all comparisons) (#3 KEY POINTS ABOUT ROBOTIC SURGERY FOR COLON CANCER): In individuals with colon cancer, robotic surgery was comparable to
laparoscopic surgery for 6 of them, namely:
• The probability of postoperative complications of any severity and of major
postoperative complications, of anastomotic leaks, of disease-free survival, as
well as the length of hospital stay and estimated blood loss.
However, compared to laparoscopic surgery, robotic surgery may lead to a relative
reduction in the risk of conversion to open surgery (level of scientific evidence: very low). (#4 KEY POINTS ABOUT ROBOTIC DISTAL PANCREATECTOMY FOR BENIGN AND MALIGNANT
PANCREATIC TUMOURS): Robotic distal pancreatectomy appears to be comparable to the laparoscopic and/or open
approaches in terms of:
• The probability of positive surgical margins, of major postoperative complications
and of major postoperative pancreatic fistulas and of postoperative pancreatic
fistulas of any severity (all comparisons). (#5 KEY POINTS ABOUT ROBOTIC WHIPPLE SURGERY FOR BENIGN AND MALIGNANT PANCREATIC
TUMOURS): Robotic Whipple surgery appears to be comparable to laparoscopic and/or open
approaches in terms of: The probability of major postoperative pancreatic fistulas (compared to open
surgery. (#6 KEY POINTS ABOUT ROUX-EN-Y GASTRIC BYPASS SURGERY FOR OBESITY): In individuals with obesity, robotic surgery was comparable to
laparoscopic surgery for all the outcomes evaluated.
• Robotic Roux-en-Y gastric bypass surgery (robot used for all or part of the
procedure) appears to be comparable to laparoscopic surgery with regard to the probability of hospital readmission (for any reason), of postoperative
complications of any severity, of conversion to open surgery, of anastomotic
leaks and of reoperation, and to the length of hospital stay and the estimated
blood loss. (#7 KEY POINTS ABOUT SLEEVE GASTRECTOMY FOR OBESITY): In individuals with obesity, robotic surgery was comparable to laparoscopic
surgery for all of the outcomes evaluated, namely, the probability of hospital readmission
for any reason, of postoperative complications of any severity, of staple line leaks and of
reoperation, and the length of hospital stay. CONCLUSION: The analysis shows that robotic surgery is at least comparable to laparoscopic surgery,
transanal surgery and open surgery in terms of safety, clinical and organizational
effectiveness for the five indications of interest. However, certain outcomes suggest
potential benefits for four of the indications (rectal and colon cancers, and benign and
malignant pancreatic tumours), with levels of scientific evidence ranging from very low to
moderate, while there are no data to support superiority regarding obesity.
Authors' methods:
The reference lists
of the selected publications were also reviewed to identify additional relevant
publications. Publications in both French and English were selected. In addition, to
narrow and contextualize the analysis, outcomes deemed important for assessing the
clinical and organizational value of robotic surgery were identified prior to the analysis,
and significance thresholds were assigned to them with the help of general surgeons and
surgeons from different specialties, including colorectal, bariatric, pancreatic and cancer
surgeons. Two scientific professionals took part in selecting publications, extracting data,
and assessing the risk of bias and levels of scientific evidence.
Details
Project Status:
Completed
Year Published:
2026
URL for published report:
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Technologies/Chirurgie_robotique_cancer_rectum_colon_pancreas_EC_INESSS.pdf
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
Canada
Province:
Quebec
MeSH Terms
- Robotic Surgical Procedures
- Colorectal Neoplasms
- Colorectal Surgical Procedures
- Carcinoma, Pancreatic Ductal
- Pancreatic Neoplasms
- Bariatric Surgery
- Obesity, Morbid
- Minimally Invasive Surgical Procedures
- Laparoscopy
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.